At an undisclosed site in Germany's Bavaria state, pharmaceutical CEO Philip Schetter opens a 75-centimeter (30-inch) thick steel door that secures his wares: vast amounts of cannabis.
May 18, 2025
0
0
Back pain, migraines, arthritis, long-term concussion symptoms, complications following cancer treatment—these are just a few of the conditions linked to chronic pain, which affects 1 in 5 adults and for which medication ...
May 16, 2025
0
72
Sepsis is a life-threatening condition triggered by the body's extreme response to infection. It causes widespread inflammation, which can lead to tissue damage, organ failure and death.
May 15, 2025
0
1
A hefty expansion to the state's narrow medical marijuana program won overwhelming approval in the Texas House on Monday, giving veterans broad access to THC treatments and raising the number of dispensaries allowed in the ...
May 13, 2025
0
0
In an effort to curb misuse of opioids and prevent overdose deaths, the College of Physicians and Surgeons of British Columbia released a legally enforceable practice standard, "Safe Prescribing of Drugs with Potential for ...
May 12, 2025
0
0
A study conducted at the State University of Campinas (UNICAMP) in Brazil investigated the process of muscle pain chronification—that is, when it goes from acute to chronic—and identified one of the mechanisms by which ...
May 8, 2025
0
23
VIVEX Biologics, Inc. sponsored research reports positive outcomes for patients with chronic lumbar discogenic pain treated using a single intradiscal injection of VIA Disc NP, an allogeneic nucleus pulposus product derived ...
A new study led by UNSW Sydney and Neuroscience Research Australia (NeuRA) shows that targeting emotional processing is key to treating and managing chronic pain.
May 6, 2025
0
0
McGill University researchers, in collaboration with colleagues in Israel and Ireland, have developed AI technology that can detect patterns in gut bacteria to identify complex regional pain syndrome (CRPS) with remarkable ...
May 6, 2025
0
2
More than one in five people prescribed extended-release painkillers such as OxyContin developed an addiction within a year, according to a newly released study mandated by the U.S. Food and Drug Administration.
May 6, 2025
0
24
